Navigation Links
Neuartiger molekularer Assay für die aktive MRSA-Überwachung weist neu entdeckte Stämme arzneimittelresistenter Supererreger nach
Date:11/26/2013

BALTIMORE, 26. November 2013 /PRNewswire/ -- BD Diagnostics, eine Sparte von BD (Becton, Dickinson and Company), einem führenden globalen Unternehmen aus der Medizintechnik, gab heute die Verfügbarkeit des mit CE-Kennzeichnung ausgestatteten BD MAX MRSA XT-Assays für den Einsatz im BD MAX™-System in Europa bekannt. Der Assay nutzt so genannte eXTended Detection Technology zum Erkennen einer breiten Spanne von Stämmen von methicillinresistentem Staphylococcus aureus (MRSA) aus Nasalabstrichen von Patienten, die von diesem arzneimittelresistenten Erreger befallen sein könnten. Es ist der einzige voll automatisierte Assay zur aktiven MRSA-Überwachung, der in MRSA (MREJ)[i]-Sequenzen undResistenzgene erkennt: mecA und das jüngst entdeckte mecC.[ii]

Die aktive Überwachung mithilfe von molekularen Tests zum schnellen Nachweisen von MRSA ist eine bewährte Strategie, um die Übertragung in Gesundheitseinrichtungen zu reduzieren und eine Infektion von geschwächten Patienten zu verhindern. Ungenaue Nachweise können zur unkontrollierten Ausbreitung von MRSA und der falschen Verwendung von Resourcen in Gesundheitseinrichtungen führen. Bei vielen handelsüblichen Assays werden Stämme von Staphylococcus aureus, denen das Gen mecA fehlt (häufig als „Dropout-Mutanten" bezeichnet), fälschlicherweise als MRSA erkannt. Diese falsche positiven Ergebnisse können eine unnötige und kostspielige Isolation und eine Überbehandlung der Patienten nach sich ziehen.[iii] MRSA-Stämme mit dem neu entdeckten mecC-Gen machen nahezu drei Prozent aller neuen MRSA-Fälle aus[iv], können jedoch von Assays, die das Gen nicht erkennen, nicht nachgewiesen werden.[v] Diese falsche negativen Ergebnisse können zu einer unkontrollierten Übertragung nicht erkannter MRSA-Stämme fü
'/>"/>

SOURCE BD (Becton, Dickinson and Company)
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
2. DermTechs Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study
3. HistoRx Licenses Melanoma Assay from Yale University
4. QIAGEN and Max Planck Institute for Infection Biology Collaborate to Develop Assay for Active TB Risk in Individuals With Latent Infection
5. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
6. Life Technologies Partners With DaAn Gene to Develop and Commercialize Molecular Diagnostic Assays in China
7. Berg Diagnostics Receives CLIA Certification and Launches Novel Vitamin D Assay
8. Cellectricon Launches Dynaflow® Resolve System Enabling Novel Ion Channel Assays
9. Roche Launches 454 Sequencing Assays for High Sensitivity Genetic Variant Detection in Leukemia Samples to Drive Blood Cancer Research Worldwide
10. QIAGEN Acquires AmniSure International to Add Unique Assay to Emerging Point of Need Portfolio
11. Cepheid Receives FDA Clearance for GeneXpert Infinity-80 System for Initial Use with Xpert Flu Assay
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Reports from CDC show ... from one or more chronic health conditions - including ... address some of these diseases, but may not eliminate ... face. While implanted nerve stimulation devices today offer relief, ... which can induce side effects. , To eliminate ...
(Date:12/19/2014)... With only 2 weeks left of 2014, ... Biohit products . The product specials include Buy 1 ... Trade-in Program, and free pipette tips. , Sartorius mLINE ... world. They are ideal for lab technicians performing long ... ,     Full volume range of 0.1 uL to 10 ...
(Date:12/19/2014)... YORK , Dec. 18, 2014 Relmada ... therapies for the treatment of chronic pain, announced the ... today. "This was a transformational year in ... promising future for our company," said Sergio Traversa ... year, we have executed on key financial, human resource ...
(Date:12/17/2014)... Achim Noack has been named global vice president ... position, Noack will assist Jerry Stoller, CEO and president ... and supervise global marketing management and implementation of new ... and experience in the crop protection industry,” says Jerry ... thinking will be a great asset for Stoller Group, ...
Breaking Biology Technology:Draper Wins GSK Funding for Smaller, Smarter Implantable Devices 2Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials 2Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Achim Noack Joins Stoller Group as Global Vice President of Marketing and Administration 2
... 11, 2011 Ardea Biosciences, Inc. (Nasdaq: ... of small-molecule therapeutics for the treatment of serious diseases, ... full-year 2010 financial results. "With approximately $160 ... we are in an excellent financial position," commented Barry ...
... 11, 2011 BioSpecifics Technologies Corp. (Nasdaq: BSTC ... collagenase-based products, today announced its financial results for the fourth ... "2010 was an exciting year for the Company, but ... forward to sales growth of XIAFLEX® in the U.S., as ...
... How fast an intense laser pulse can change the ... Kiel University in the current edition of Nature ... Bauer, Dr. Kai Ronagel and Professor Lutz Kipp from ... colleagues from the University of Kaiserslautern and the University ...
Cached Biology Technology:Ardea Biosciences Reports Recent Accomplishments and Announces Fourth Quarter and Full-Year 2010 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Fourth Quarter and Full-Year 2010 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Fourth Quarter and Full-Year 2010 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Fourth Quarter and Full-Year 2010 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Fourth Quarter and Full-Year 2010 Financial Results 6BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2010 Financial Results 2BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2010 Financial Results 3BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2010 Financial Results 4BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2010 Financial Results 5BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2010 Financial Results 6BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2010 Financial Results 7
(Date:12/5/2014)... Dec. 4, 2014  Tute Genomics, a leader in ... in Series A1 funding led by UK-based Eurovestech. Peak ... in the investment round. "We are at ... adopts next-generation sequencing and seeks new approaches for the ... Robison , MD MBA, and CEO of Tute Genomics. ...
(Date:11/21/2014)... According to a new market ... RFID, Access Control, Intrusion Detection, Parking Management, Under Vehicle ... Service Geography - Global Forecasts to 2020", published by ... be around $25 Billion in 2014 and is expected ... CAGR of 8.69%. Browse 116 market data ...
(Date:11/21/2014)...   Atmel® Corporation (NASDAQ: ATML ... technology solutions, today launched the industry,s first family of ... V cc range from 1.7V to 5.5V. The ... 2 C bus communication speeds, and are available with ... ideal for consumer, industrial, computer, and medical applications. ...
Breaking Biology News(10 mins):Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4
... In January 2001, the world held its breath when the ... reef and began breaking up in the heart of one ... the Galapagos Islands. At risk were vast numbers ... by Charles Darwin that contributed to his landmark theory of ...
... skull, is estimated to affect one out of every 2,000 ... procedures to correct the problems. One procedure was to make ... of the infant and reshape the skull by breaking the ... incision near the point of the fused skull plates. Now, ...
... Michael Goodisman could be called the Maury Povich of ... the paternity of yellow jackets to study family dynamics ... within a colony, each yellow jacket queen mates with ... insects such as yellow jackets have been described as ...
Cached Biology News:First wind turbines on Galapagos Islands will halve diesel imports, reduce risk of future oil spills 2First wind turbines on Galapagos Islands will halve diesel imports, reduce risk of future oil spills 3First wind turbines on Galapagos Islands will halve diesel imports, reduce risk of future oil spills 4Craniosynostosis minimally invasive surgery holds more promise than old procedure 2Research uncovers the social dynamics of yellow jackets 2Research uncovers the social dynamics of yellow jackets 3Research uncovers the social dynamics of yellow jackets 4
... FLA-5000 imaging system allows scanning ... as large as 40 x ... as 25 microns. This system ... electrophoresis in the proteomics field ...
... The Caliper Sciclone ALH 3000 workstation automates ... applications, from Genomic and Proteomic Sample Preparation ... The modular design of the Caliper ... and accessories to perfectly meet the needs ...
Designed for use with the Agencourt SprintPrep 384 kit and all MCPrep reagent kits. Used with flat bottom 96-well microplates such as deep well plates used to culture bacteria....
... platform for fully automated systems for a ... be configured for applications ranging from compound ... closed loop screening, which means it has ... cherry picking and follow up studies all ...
Biology Products: